2005;32(4):37995, v
The science behind this program addresses the specific physiological changes caused by GLP-1 receptor agonists, such as slowed digestion and altered insulin release
Other possible medication interactions include disruption of estrogen therapy, slowed glucuronidated drug clearance, and accelerated absorption of Pglycoprotein substrates
Skipping doses or extending the interval between injections can reduce effectiveness and increase hunger cravings, potentially stalling weight loss momentum
If you or a member of your family received semaglutide injections for weight loss and experienced side effects like gastroparesis (stomach paralysis), persistent vomiting, nausea, or diarrhea, you may qualify for an Ozempic lawsuit
If a GLP-1 is not available or not affordable for you, there are still many other effective tools for improving your diabetes control and weight